ABBOTT LABORATORIES (NYSE:ABT)

Headlines for ABBOTT LABORATORIES

Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
The Wall Street Transcript - Nov 20, 2009
November 20, 2009 - The Wall Street Transcript has just published Pharmaceuticals Report offering a timely review of the Pharmaceuticals sector. This Special Report contains expert industry ...
Abbott Hesitates To Promote Niaspan Study Due To FDA Rules
Easy Bourse - Nov 19, 2009
By Peter Loftus Of DOW JONES NEWSWIRES You might think Abbott Laboratories' (ABT) would be trumpeting to doctors and consumers a new study showing the benefits of cholesterol drug Niaspan. The ...
The Deal Names Abbott Top Dealmaker for Second Consecutive Year
PR Newswire - Nov 19, 2009
ABBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstCall/ -- The Deal magazine has named Abbott (NYSE: ABT) as one of its Most Admired Corporate Dealmakers for the second consecutive year. The Deal ...
Deal Economy 2010: Corporate dealmakers on strategy
The Daily Deal - Nov 19, 2009
Following the keynote by Weil, Gotshal & Manges LLP partner Harvey R. Miller, Corporate Dealmaker editor Kenneth Klee oversaw a panel of dealmakers from major corporations who discussed their ...
Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform
WebWire - Nov 18, 2009
Abbott Park, Illinois and Waltham, Massachusetts, — Abbott (NYSE: ABT) and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that ...